Fragment 176-191 Specifications Molecular Formula : C 78 H 125 N 23 O 23 S 2 Molecular Weight : 1817.1 g/mol Sequence : Tyr-Leu-Arg-Ile-Val-Gin-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe CJC-1295 (Mod GRF 1-29) Specifications Molecular Formula: C 152 H 252 N 44 O 42 Molecular Weight: 3367.954 g/mol Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2 Note: DOES NOT CONTAIN DAC Ipamorelin Specifications Molecular Formula: C 38 H 49 N 9 O 5 Molecular Weight: 711.86 g/mol Sequence: Aib-His-D-2Nal-D-Phe-Lys-NH2 Fragment 176-191 & CJC-1295 & Ipamorelin Peptide Blend Research Studies in animal models have suggested the potential breadth of impact of Fragment 176-191, a short stretch of growth hormone (hGH), in promoting fat mobilization and triggering a metabolic shift towards the perpetuation of lean body mass
This distinguishes it from GHRP 6 and hexarelin, which stimulate appetite and raise cortisol
People with active cancer or a history of certain cancers Pregnant or nursing women Children and adolescents under 18 People with certain pituitary, thyroid, or adrenal conditions Anyone with severe diabetes or uncontrolled blood sugar People taking medications that may interact with growth hormone peptides Our Medical Director reviews your full health history during your consultation to make sure peptide therapy is safe for you
What GHRP-6 contributes that neither of the other compounds can replicate is the gastric motility component GHRP-6 accelerates gastric emptying through ghrelin receptor activation in gut vagal afferents, a pathway thats both a potential confounder in some study designs and the entire point in others
pentose phosphate pathway) and guanosine triphosphate (purine pathway) (Sabry et al., 1993